🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
NAG
$NAGE
🔒 US EquitiesNiagen Bioscience Inc
AVG HISTORICAL GAP
+7.47%
MAX GAP RECORD
+19.82%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $NAGE
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$NAGE
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE) |
-10.37%
|
| May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE) |
-12.27%
|
| Mar 04, 2026 Earnings Release 2026-03-04 (AFTER CLOSE) |
+15.18%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE) |
+8.63%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE) |
+19.15%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+5.21%
|
| Mar 04, 2025 Earnings Release 2025-03-04 (AFTER CLOSE) |
+19.82%
|
| Oct 31, 2024 Earnings Release 2024-10-31 (AFTER CLOSE) |
+18.05%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
11.2%
Bullish Gaps (9)
Bearish Gaps (2)
Neutral / Flat (1)
📖 Intelligence Summary
Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗